Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

H2Q7T9 (H2Q7T9_PANTR) Pan troglodytes (Chimpanzee)

Coagulation factor X UniProtKBInterProSTRINGInteractive Modelling

488 aa; Sequence (Fasta) ; 4 identical sequences: Homo sapiens: P00742, Q5JVE7; Pan troglodytes: A0A6D2WHH3; Pan paniscus: A0A2R9B696

Available Structures

158 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Cryo-em structure of human prothrombin:prothrombinase at 4.1 Angstrom resolution Heteromer
P00734; P00742; P12259;
41-488
Assess
Cryo-em structure of human prothrombinase on a nanodisc at 5.3 Angstrom resolution Heteromer
P00742; P12259;
41-488
Assess
Crystal Structure of Blood Coagulation Factor Xa in Complex with Ecotin M84R Heteromer
P00742; P23827;
43-469
MG;NA;
Assess
Crystal structure of human FXA in complex with methyl (2Z)-3-[(3-chloro-1H-indol-7-yl)amino]-2-cyan… Heteromer
P00742;
90-472
GOL;ENS;CA;NA;MES;ACT;
Assess
STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKI… Heteromer
P00742;
128-475
Assess
STRUCTURE OF HUMAN DES(1-45) FACTOR XA AT 2.2 ANGSTROMS RESOLUTION Heteromer
P00742;
129-475
Assess
X-ray crystal structure of human FXA in complex with 6-chloro-N-((3S)-2-oxo-1-(2-oxo-2-((5S)-8-oxo-… Heteromer
P00742;
122-467
FI1;NA;CA;GOL;
Assess
FACTOR XA INHIBITOR COMPLEX Heteromer
P00742;
125-469
CA;T87;
Assess
COAGULATION FACTOR XA INHIBITOR COMPLEX Heteromer
P00742;
125-469
CA;DX9;
Assess
FACTOR XA INHIBITOR COMPLEX Heteromer
P00742;
125-469
CA;R11;
Assess
Factor Xa inhibitor complex Heteromer
P00742;
126-469
894;CA;MG;
Assess
Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with aminoindane and… Heteromer
P00742;
126-469
C0Z;CA;MG;
Assess
Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with aminoindane and… Heteromer
P00742;
126-469
439;CA;MG;
Assess
The discovery of potent and long-acting oral factor Xa inhibitors with tetrahydroisoquinoline and b… Heteromer
P00742;
126-469
MZA;CA;MG;
Assess
Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with biaryl P4 motifs Heteromer
P00742;
125-468
GSV;
Assess
Crystal structure of factor Xa in complex with compound "1 Heteromer
P00742;
126-469
CA;IIA;
Assess
Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with aminoindane and… Heteromer
P00742;
126-469
930;CA;MG;
Assess
factor Xa in complex with the dual thrombin-FXa inhibitor 58. Heteromer
P00742;
126-469
CA;7R9;
Assess
Factor Xa in complex with the dual thrombin-FXa inhibitor 57. Heteromer
P00742;
126-469
CA;6XS;
Assess
Structure of the C3bB proconvertase in complex with lufaxin and factor Xa Heteromer
P00742; P00751; P01024; Q5WPU8;
126-469
NAG;MG;NAG;
Assess
Factor Xa complex with GTC000101 Heteromer
P00742;
126-468
48U;
Assess
Structure and property based design of factor Xa inhibitors:biaryl pyrrolidin-2-ones incorporating … Heteromer
P00742;
126-468
CA;MG;GSI;
Assess
Selective and Dual Action Orally Active Inhibitors of Thrombin and Factor Xa Heteromer
P00742;
126-468
701;
Assess
Factor Xa complex with GTC000441 Heteromer
P00742;
126-468
CA;44I;
Assess
Factor XA in complex with a cis-1,2-diaminocyclohexane derivative Heteromer
P00742;
125-467
CA;D14;
Assess
factor Xa in complex with D46-5241 Heteromer
P00742;
125-467
CA;D46;
Assess
Factor Xa complex with GTC000398 Heteromer
P00742;
126-468
CA;48W;
Assess
CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX Heteromer
P00742;
126-468
GSJ;CA;
Assess
Factor Xa complex with GTC000102 Heteromer
P00742;
126-468
CA;MG;4O5;
Assess
Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with monoaryl P4 mot… Heteromer
P00742;
126-468
461;
Assess
Selective and Dual Action Orally Active Inhibitors of Thrombin and Factor Xa Heteromer
P00742;
126-468
895;
Assess
Factor Xa complex with GTC000422 Heteromer
P00742;
126-468
CA;MG;987;
Assess
Factor Xa complex with GTC000401 Heteromer
P00742;
126-468
CA;4O1;
Assess
CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR132747 Heteromer
P00742;
126-468
CA;RRP;
Assess
CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX Heteromer
P00742;
126-468
G15;CA;
Assess
CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR200095 Heteromer
P00742;
126-468
CA;RTR;
Assess
Factor Xa complex with GTC000406 Heteromer
P00742;
126-468
CA;MG;4O6;
Assess
FACTOR XA IN COMPLEX WITH THE INHIBITOR (1S,2R,4S)-N1-[(5-chloroindol-2-yl)carbonyl]-4-(N,N-dimethy… Heteromer
P00742;
125-467
CA;DT8;
Assess
CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208944 Heteromer
P00742;
126-468
CA;RDR;
Assess
Factor Xa in complex with D102-4380 Heteromer
P00742;
125-467
CA;D1Q;
Assess
Crystal structure of factor Xa in complex with 43 Heteromer
P00742;
126-468
IID;CA;
Assess
Factor Xa in complex with the inhibitor 2-[[4-[(5-chloroindol-2-yl)sulfonyl]piperazin-1-yl] carbony… Heteromer
P00742;
125-467
CA;D01;
Assess
Aminopyrrolidine Factor Xa inhibitor Heteromer
P00742;
126-468
H22;CA;NA;
Assess
FACTOR XA IN COMPLEX WITH THE INHIBITOR (-)-cis-N1-[(5-Chloroindol-2-yl)carbonyl]-N2-[(5-methyl-4,5… Heteromer
P00742;
125-467
CA;D92;
Assess
FACTOR XA IN COMPLEX WITH THE INHIBITOR trans-N1-[(5-Chloroindol-2-yl)carbonyl]-N2-[(5-methyl-4,5,6… Heteromer
P00742;
125-467
CA;D93;
Assess
Factor Xa in complex with the inhibitor 4-[(5-chloroindol-2-yl)sulfonyl]-2-(2-methylpropyl)-1-[[5-(… Heteromer
P00742;
125-467
CA;D91;
Assess
Factor Xa in complex with a potent 2-amino-ethane sulfonamide inhibitor Heteromer
P00742;
126-468
CA;A7I;
Assess
factor Xa in complex with the dual thrombin-FXa inhibitor 31. Heteromer
P00742;
127-469
CA;VYR;
Assess
Human coagulation factor Xa in complex with M55159 Heteromer
P00742;
127-469
CA;XME;
Assess
Human coagulation factor Xa in complex with M55192 Heteromer
P00742;
127-469
CA;XMC;
Assess
Human coagulation factor Xa in complex with M54471 Heteromer
P00742;
127-469
CA;XMK;
Assess
Crystal structure of factor Xa in complex with 50 Heteromer
P00742;
126-468
CA;I1H;
Assess
Human coagulation factor Xa in complex with M54476 Heteromer
P00742;
127-469
CA;XMJ;
Assess
Human coagulation factor Xa in complex with M55590 Heteromer
P00742;
127-469
CA;XMB;
Assess
Human coagulation factor Xa in complex with M55532 Heteromer
P00742;
127-469
CA;XMA;
Assess
Human coagulation factor Xa in complex with M55125 Heteromer
P00742;
127-469
CA;XMG;
Assess
CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45 Heteromer
P00742;
126-468
CA;IIE;
Assess
Crystal structure of factor Xa in complex with 21 Heteromer
P00742;
126-468
CA;IIB;
Assess
Human coagulation factor Xa in complex with M55143 Heteromer
P00742;
127-469
CA;XMF;
Assess
Human coagulation factor Xa in complex with M55124 Heteromer
P00742;
127-469
CA;XMH;
Assess
Human coagulation factor Xa in complex with M55165 Heteromer
P00742;
127-469
CA;XMD;
Assess
Human coagulation factor Xa in complex with M55113 Heteromer
P00742;
127-469
CA;XMI;
Assess
Crystal Structure of the Antithrombin-S195A Factor Xa-Pentasaccharide Complex Heteromer
P00742; P01008;
126-468
NAG;ZDO;CA;NAG;
Assess
Factor Xa - cation inhibitor complex Heteromer
P00742;
127-468
BI7;CA;NA;
Assess
FACTOR XA - CATION INHIBITOR COMPLEX Heteromer
P00742;
127-468
FJD;NA;
Assess
FACTOR XA - CATION INHIBITOR COMPLEX Heteromer
P00742;
127-468
XWG;NA;
Assess
FACTOR XA - CATION INHIBITOR COMPLEX Heteromer
P00742;
127-468
Y5H;NA;
Assess
Factor XA in complex with the inhibitor (R)-6-(2'-((3- HYDROXYPYRROLIDIN-1-YL)METHYL)BIPHENYL-4-YL)… Heteromer
P00742;
127-468
FFG;
Assess
Factor XA in complex with the inhibitor N-(2-(((5-chloro-2-pyridinyl) amino)sulfonyl)phenyl)-4-(2-o… Heteromer
P00742;
127-468
FXA;
Assess
Aminopyrrolidine Factor Xa inhibitor Heteromer
P00742;
128-469
LZG;CA;NA;CL;
Assess
Aminopyrrolidine Factor Xa inhibitor Heteromer
P00742;
128-469
H25;CA;NA;CL;
Assess
Factor Xa - cation Heteromer
P00742;
127-468
784;NA;
Assess
Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor Heteromer
P00742;
127-468
CA;NA;IVK;
Assess
Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with aminoindane and… Heteromer
P00742;
126-467
931;CA;MG;
Assess
Aminopyrrolidine-related triazole Factor Xa inhibitor Heteromer
P00742;
127-468
H21;CA;NA;
Assess
Factor xa in complex with the inhibitor 3-chloro-N-((1R,2S)-2-(4-(2-oxopyridin-1(2H)-yl)benzamido)c… Heteromer
P00742;
127-468
ME4;
Assess
Factor XA in complex with the inhibitor 1-(3'-amino-1,2-benzisoxazol-5'-yl)-n-(4-(2'-((dimethylamin… Heteromer
P00742;
127-468
IK8;
Assess
Factor Xa complex with GTC000006 Heteromer
P00742;
127-468
CA;4O4;
Assess
CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX Heteromer
P00742;
126-467
GSQ;
Assess
Factor xa in complex with the inhibitor 5-chloro-N-(2-(4-(2-oxopyridin-1(2H)-yl)benzamido)ethyl)thi… Heteromer
P00742;
127-468
ME1;
Assess
Factor XA in complex with the inhibitor 1-[2-(aminomethyl)phenyl]-N-(3-fluoro-2'-sulfamoylbiphenyl-… Heteromer
P00742;
127-468
M37;CA;
Assess
CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031) COMPLEXED WITH FACTOR XA Heteromer
P00742;
127-468
CA;CL;Z34;GOL;
Assess
Aminopyrrolidine Factor Xa inhibitor Heteromer
P00742;
126-467
LZI;NA;
Assess
Factor Xa in complex with a phenylenediamine derivative Heteromer
P00742;
126-467
CA;D90;
Assess
CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX Heteromer
P00742;
127-468
GSX;CA;
Assess
CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX Heteromer
P00742;
127-468
GS6;CA;
Assess
Factor Xa in complex with BAY59-7939 Heteromer
P00742;
127-468
RIV;CA;
Assess
CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX Heteromer
P00742;
127-468
GS5;CA;
Assess
Crystal structure of a Human Factor Xa inhibitor complex Heteromer
P00742;
127-468
CA;GSK;
Assess
Crystal Structure of Human Coagulation Factor XA Complexed with FXV673 Heteromer
P00742;
127-468
CA;FXV;
Assess
Factor Xa in complex with the inhibitor 3-(6-(2'-((dimethylamino)methyl)-4-biphenylyl)-7-oxo-3-(tri… Heteromer
P00742;
127-468
4QC;
Assess
Factor XA in complex with the inhibitor 1-[3-(aminomethyl)phenyl]-N-[3-fluoro-2'-(methylsulfonyl)bi… Heteromer
P00742;
127-468
M35;CA;
Assess
Factor xa in complex with the inhibitor 5-chloro-N-((1R,2S)-2-(4-(2-oxopyridin-1(2H)-YL)benzamido) … Heteromer
P00742;
127-468
ME5;
Assess
FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-(4-methoxyphenyl)-6-(4-(1-(pyrrolidin-1-ylmethyl)cyclopro… Heteromer
P00742;
127-468
CA;LG0;
Assess
Factor xa in complex with the inhibitor 6-(2'- (methylsulfonyl)biphenyl-4-yl)-1-(3-(5-oxo-4,5-dihyd… Heteromer
P00742;
127-468
LGK;NA;
Assess
Factor Xa in complex with the inhibitor 1-(3-amino-1,2-benzisoxazol-5-yl)-6-(2'-(((3r)-3-hydroxy-1-… Heteromer
P00742;
127-468
5QC;
Assess
Factor xa in complex with the inhibitor n-(3-fluoro-2'- (methylsulfonyl)biphenyl-4-yl)-1-(3-(5-oxo-… Heteromer
P00742;
127-468
LGJ;NA;
Assess
Factor Xa in Complex with the Inhibitor APIXABAN (BMS-562247) AKA 1-(4-METHOXYPHENYL)-7-OXO-6-(4-(2… Heteromer
P00742;
127-468
CA;GG2;
Assess
Factor xa in complex with the inhibitor 3-methyl-1-(3-(5- oxo-4,5-dihydro-1h-1,2,4-triazol-3-yl)phe… Heteromer
P00742;
127-468
LGM;NA;
Assess
Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with monoaryl P4 mot… Heteromer
P00742;
126-467
898;
Assess
Anti-FX Fab of mim8 in complex with human FXa Heteromer
P00742;
127-468
0GJ;CA;
Assess
Factor xa in complex with the inhibitor 1-(3-(5-oxo-4,5- dihydro-1h-1,2,4-triazol-3-yl)phenyl)-6-(2… Heteromer
P00742;
127-468
LGL;NA;
Assess
Crystal structure of the factor Xa/NAP5 complex Heteromer
P00742; Q16940;
128-469
NA;
Assess
Crystal structure of human factor XA complexed with 3-chloro-N-(4-chloro-2-{[(5-chloropyridin-2-yl)… Heteromer
P00742;
127-467
CA;663;
Assess
Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor Heteromer
P00742;
129-469
XBV;CA;NA;
Assess
Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor Heteromer
P00742;
129-469
OYJ;CA;NA;
Assess
Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor Heteromer
P00742;
129-469
455;CA;NA;
Assess
Aminopyrrolidine Factor Xa inhibitor Heteromer
P00742;
129-469
LZH;CL;CA;NA;
Assess
Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor Heteromer
P00742;
129-469
RR8;CA;NA;
Assess
Crystal Structure of FXa in complex with 4,4-disubstituted pyrrolidine-1,2-dicarboxamide inhibitor 2 Heteromer
P00742;
128-468
CA;L1C;
Assess
The discovery of glycine and related amino acid-based factor xa inhibitors Heteromer
P00742;
128-468
CA;FXI;
Assess
Crystal structure of human factor XA complexed with 3-Chloro-4-(2-methylamino-imidazol-1-ylmethyl)-… Heteromer
P00742;
127-467
CA;CL;993;
Assess
Aminopyrrolidine Factor Xa inhibitor Heteromer
P00742;
127-467
LZF;CA;NA;
Assess
Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor Heteromer
P00742;
129-469
63C;CA;NA;
Assess
Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor Heteromer
P00742;
129-469
8NC;CA;NA;
Assess
Crystal Structure of FXa in complex with 4,4-disubstituted pyrrolidine-1,2-dicarboxamide inhibitor 1 Heteromer
P00742;
128-468
L1D;CA;
Assess
Crystal Structure of 3-chloro-N-[4-chloro-2-[[(5-chloro-2-pyridinyl)amino]carbonyl]-6-methoxyphenyl… Heteromer
P00742;
127-467
CA;XLD;GOL;
Assess
CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815 Heteromer
P00742;
128-468
CA;815;
Assess
Crystal Structure of 3-chloro-N-[4-chloro-2-[[(4-chlorophenyl)amino]carbonyl]phenyl]-4-[(4-methyl-1… Heteromer
P00742;
127-467
CA;XLC;GOL;
Assess
Crystal Structure of Human Coagulation Factor XA Complexed with RPR208707 Heteromer
P00742;
128-468
CA;PR2;
Assess
CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR209685 Heteromer
P00742;
128-468
CA;RRR;
Assess
Human factor Xa in complex with synthetic inhibitor benzylsulfonyl-dSer(Benzyl)-Gly-4-amidinobenzyl… Heteromer
P00742;
128-468
CA;6PK;
Assess
CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515 Heteromer
P00742;
128-468
CA;RPR;
Assess
Factor Xa in complex with the inhibitor 1-[6-methyl-4,5,6,7-tetrahydrothiazolo(5,4-c)pyridin-2-yl] … Heteromer
P00742;
127-467
CA;D76;
Assess
Factor XA in complex with (R)-2-(1-ADAMANTYLCARBAMOYLAMINO)-3-(3-CARBAMIDOYL-PHENYL)-N-PHENETHYL-PR… Heteromer
P00742;
128-468
CA;RUP;
Assess
An Orally Efficacious Factor Xa Inhibitor Heteromer
P00742;
128-468
CA;230;
Assess
X-ray Structure of FXa in complex with 7-fluoroindazole Heteromer
P00742;
128-468
JNJ;
Assess
Discovery of Tetrahydropyrimidin-2(1H)-one derivative TAK-442: A potent, selective and orally activ… Heteromer
P00742;
127-466
443;EDO;CA;
Assess
Factor XA inhibitor Heteromer
P00742;
129-468
CA;237;
Assess
DesGla-XaS195A Bound to Aptamer 11F7t Heteromer
P00742;
128-467
NA;CA;MG;
Assess
DesGla-XaS195A Bound to Aptamer 11F7t and Rivaroxaban Heteromer
P00742;
128-467
RIV;NA;CA;MG;
Assess
Crystal Structure of FXa/selectide/NAPC2 ternary complex Heteromer
P00742; Q16938;
129-467
PO4;ACT;NA;
Assess
Aspartyl/Asparaginyl beta-hydroxylase (AspH) H679A in complex with Mn, NOG and Factor X peptide fra… Heteromer
P00742; Q12797;
97-116
MN;OGA;GOL;
Assess
Aspartyl/Asparaginyl beta-hydroxylase (AspH) H679A in complex with Factor X peptide fragment (39mer… Heteromer
P00742; Q12797;
97-116
FMT;GOL;
Assess
Aspartyl/Asparaginyl beta-hydroxylase (AspH) oxygenase and TPR domains in complex with manganese, 3… Heteromer
P00742; Q12797;
99-116
MN;Q1Z;
Assess
Aspartyl/Asparaginyl beta-hydroxylase (AspH) oxygenase and TPR domains in complex with L-2-hydroxyg… Heteromer
P00742; Q12797;
99-116
MN;S2G;
Assess
Aspartyl/Asparaginyl beta-hydroxylase (AspH) oxygenase and TPR domains in complex with manganese, 3… Heteromer
P00742; Q12797;
99-116
MN;U4B;
Assess
Aspartyl/Asparaginyl beta-hydroxylase (AspH) oxygenase and TPR domains in complex with D-4-hydroxy-… Heteromer
P00742; Q12797;
99-116
MN;IO9;
Assess
Aspartyl/Asparaginyl beta-hydroxylase (AspH) oxygenase and TPR domains in complex with manganese, 5… Heteromer
P00742; Q12797;
99-116
MN;U4Q;
Assess
Aspartyl/Asparaginyl beta-hydroxylase (AspH) oxygenase and TPR domains in complex with manganese, 3… Heteromer
P00742; Q12797;
99-116
GOL;MN;QA8;
Assess
Aspartyl/Asparaginyl beta-hydroxylase (AspH) oxygenase and TPR domains in complex with (S)-4-hydrox… Heteromer
P00742; Q12797;
99-116
MN;GOL;IOW;
Assess
Aspartyl/Asparaginyl beta-hydroxylase (AspH) H725A in complex with Factor X peptide fragment (39mer… Heteromer
P00742; Q12797;
99-116
GOL;PPI;
Assess
Aspartyl/Asparaginyl beta-hydroxylase (AspH) oxygenase and TPR domains in complex with D-2-hydroxyg… Heteromer
P00742; Q12797;
99-116
GOL;MN;2HG;
Assess
Aspartyl/Asparaginyl beta-hydroxylase (AspH)oxygenase and TPR domains in complex with manganese, N-… Heteromer
P00742; Q12797;
99-116
MN;OGA;ACT;
Assess
Aspartyl/Asparaginyl beta-hydroxylase (AspH)oxygenase and TPR domains in complex with manganese, N-… Heteromer
P00742; Q12797;
99-116
MN;OGA;ACT;
Assess
Aspartyl/Asparaginyl beta-hydroxylase (AspH) oxygenase and TPR domains in complex with manganese, N… Heteromer
P00742; Q12797;
99-116
MN;BR;GOL;UQK;
Assess
Aspartyl/Asparaginyl beta-hydroxylase (AspH)oxygenase and TPR domains in complex with manganese, 2,… Heteromer
P00742; Q12797;
99-116
MN;PD2;BR;GOL;
Assess
Aspartyl/Asparaginyl beta-hydroxylase (AspH) oxygenase and TPR domains in complex with manganese, 2… Heteromer
P00742; Q12797;
99-116
MN;AKG;
Assess
Aspartyl/Asparaginyl beta-hydroxylase (AspH) oxygenase and TPR domains in complex with manganese, 4… Heteromer
P00742; Q12797;
99-116
MN;Q1W;
Assess
Aspartyl/Asparaginyl beta-hydroxylase (AspH)oxygenase and TPR domains in complex with manganese, N-… Heteromer
P00742; Q12797;
99-111
MN;OGA;
Assess
X-ray crystal structure of human fxa in complex with (S)-N-((2-METHYLBENZOFURAN-5-YLAMINO)(2-OXO-1-…homo-2-mer90-472
GOL;MBM;CA;NA;
Assess
Crystal structure of human FxA in complex with (S)-2-cyano-1-(2-methylbenzofuran-5-yl)-3-(2-oxo-1-(…homo-2-mer90-472
GOL;YET;CA;NA;MES;ACT;DMS;
Assess
FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S)-(3'-AMIDINO-3-BIPHENYLYL)-5-(4-PYRIDYL…homo-2-mer88-469
CA;4PP;
Assess
FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S)-(3'-AMIDINO-3-BIPHENYLYL)-5-(4-PYRIDYL…homo-2-mer89-469
CA;4PP;
Assess
CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79.monomer126-178
Assess
CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125.monomer126-178
Assess
CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41.monomer126-178
Assess
CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45.monomer126-178
Assess

4 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
1p0s.1.Amonomer0.5743-178
100.00
Assess
5edm.1.Amonomer0.5541-470
37.30
Assess
4o03.1.Amonomer0.5241-469
CA;36.68
Assess
5edk.1.Amonomer0.5246-470
37.06
Assess